PDUFA REAUTHORIZATION LINKED TO FDA MANAGEMENT CHANGES BY REP. BARTON; USER FEE BILL HINGES ON APPROPRIATIONS PROCESS, SAYS HEALTH SUBCMTE. CHAIRMAN BILIRAKIS
House Commerce/Oversight Subcommittee Chairman Barton (R-Tex.) is continuing to push for management changes at FDA as a higher priority than user fee reauthorization.
You may also be interested in...
Rep. Billy Tauzin's resignation from the chairmanship of the Energy & Commerce Committee paves the way for negotiations to begin in earnest for him to take over as president of the Pharmaceutical Research & Manufacturers of America
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011